Imaging and biodistribution of <sup>99</sup>Tc<sup>m</sup> labeled peptide high-binding VEGF receptor 3 in nude mice with ovarian cancer

王玲; 梁志清; 侍立峰; 杨明福; 刘广元

您当前的位置：

首页 >

文章列表页 >

Imaging and biodistribution of ⁹⁹Tc^m labeled peptide high-binding VEGF receptor 3 in nude mice with ovarian cancer

更新时间：2026-01-09

- Imaging and biodistribution of ⁹⁹Tc^m labeled peptide high-binding VEGF receptor 3 in nude mice with ovarian cancer
- Journal of Army Medical University Vol. 31, Issue 21, Pages: 2050-2052(2009)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R73-354;R737.31;R817
- Published：2009
- 稿件说明：
移动端阅览
王玲,梁志清,侍立峰,杨明福,刘广元.99Tcm标记VEGFR-3高亲和融合多肽在荷人卵巢癌裸鼠体内的分布和显像研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(21):2050-2052.

　WANG Ling,LIANG Zhi-qing,SHI Li-feng,YANG Ming-fu,LIU Guang-yuan.Imaging and biodistribution of 99Tcm labeled peptide high-binding VEGF receptor 3 in nude mice with ovarian cancer[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(21):2050-2052.
王玲,梁志清,侍立峰,杨明福,刘广元.99Tcm标记VEGFR-3高亲和融合多肽在荷人卵巢癌裸鼠体内的分布和显像研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(21):2050-2052. DOI：

　WANG Ling,LIANG Zhi-qing,SHI Li-feng,YANG Ming-fu,LIU Guang-yuan.Imaging and biodistribution of 99Tcm labeled peptide high-binding VEGF receptor 3 in nude mice with ovarian cancer[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(21):2050-2052. DOI：

摘要

目的研究

标记VEGFR-3高亲和融合肽(phage-SHSWHWLPNLRHYAS)在荷人卵巢癌裸鼠体内分布和放射免疫定位显像。方法用NHS-MAG3为双功能鳌合剂，固相法合成多肽。

预亚锡直接标记法进行标记，纸层析法测定标记率。经尾静脉注射于荷瘤鼠体内，取不同时相进行SPECT显像，测定标记物在体内的分布情况并进行分析。结果融合多肽的

标记率为95.27%，放射化学纯度为96%，放射性浓度24.6 MBq/ml。经鼠尾静脉注射后1 h，植瘤部位开始出现放射性浓集，肾脏、肝脏及膀胱组织也可见显像；注射后3 h肿瘤显像最清晰，每克组织注射百分剂量率（%ID/g）为（30.20±6.89）。其余大部分脏器的T/NT值均达最高，最高为肌肉（13.13）；注射后4 h肿瘤部位显像逐渐消退。对照组裸鼠的肿瘤部位始终未见显像。结论筛选获得的VEGFR-3高亲和融合肽能够靶向荷瘤鼠体内肿瘤组织，实现肿瘤的靶向受体显像。

Abstract

Objective To investigate the imaging and biodistribution of

labeled peptide (phage-SHSWHWLPNLRHYAS) high-binding VEGF receptor 3 in nude mice with ovarian cancer. Methods We used NHS-MAG3 as the bifunctional chelating agent and synthesized the peptide above. It was completed with pre-stannous direct labeling by

and then the labeling efficiency was determined by paper chromatography. The tumor bearing mice were injected via tai

l veins with radiolabeled peptide. The tumors were imaged with single photon emission computed tomography (SPECT). We measured and calculated the biodistribution of the radiolabeled peptide. Results The labeled rate was 95.27% and the radiochemical purity was 96%. Under a SPECT apparatus

we observed tumor location image at 1 h post injection and the tumor images was the clearest at 3 h post injection

with the injected dose per gram of tissue (%ID/g) of (30.20±6.89) at the tumor sites. The tumor/muscle ratio was 13.13. Conclusion Our peptide can accumulate in the tumor masses. It is hopeful to be used as an ovarian cancer targeting vector for diagnosis and therapy of the cancer.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Synthesis of anti-CAⅨ proteoglycanlike region peptide and evaluation of its target binding ability

Biodistribution and imaging of ¹⁸⁸Re-labeled peptides derived from VEGF_125-136 in A549 tumor bearing nude mice

Targeting therapy for human ovarian cancer transplanted into nude mice with ¹³¹I-labeled high affinity fusion polypeptide VEGF receptor 3

High affinity peptides binding to LPS screened from phage display random peptide library

Pharmacokinetics of VEGF125-136 in rabbits by radionuclide tracing

Related Author

方可敬

徐丹

黄海韵

熊星宇

范校周

郭燕丽

朱连华

谢来平

Related Institution

Department of Gastroenterology， Second Affiliated Hospital， Army Medical University （Third Military Medical University）

⁰

Imaging and biodistribution of 99Tcm labeled peptide high-binding VEGF receptor 3 in nude mice with ovarian cancer

DOI：

摘要

Abstract

关键词

Keywords

references

Imaging and biodistribution of ⁹⁹Tc^m labeled peptide high-binding VEGF receptor 3 in nude mice with ovarian cancer